A systematic overview of VIP in experimental autoimmune encephalomyelitis (the MS product) located that VIP administration diminished clinical severity scores by 40–sixty five% across 12 independent reports, with histological Assessment exhibiting reduced CNS infiltration of Th1 and Th17 cells and amplified Foxp3+ Tregs during the spinal wire.Sci